177 related articles for article (PubMed ID: 1509994)
1. Long-term follow-up of patients with inducible supraventricular tachycardia treated with flecainide or propafenone: therapy guided by transesophageal electropharmacologic testing.
Furlanello F; Guarnerio M; Inama G; Vergara G; Del Greco M; Bertoldi A; Dallago M
Am J Cardiol; 1992 Aug; 70(5):19A-25A. PubMed ID: 1509994
[TBL] [Abstract][Full Text] [Related]
2. [Electropharmacological test with class-I C drugs in paroxysmal supraventricular re-entrant tachycardia: is a negative result with a drug predictive of the ineffectiveness of other drugs of the same class?].
Inama G; Furlanello F; Braito G; Guarnerio M; Vergara G
G Ital Cardiol; 1991 Feb; 21(2):131-8. PubMed ID: 1907937
[TBL] [Abstract][Full Text] [Related]
3. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of propafenone and flecainide in a patient with reciprocating supraventricular tachycardia.
Montenero AS; Natale A; di Bona G; Calvi V; Santarelli P; Manzoli U
Cardiologia; 1990 Mar; 35(3):253-6. PubMed ID: 2123130
[TBL] [Abstract][Full Text] [Related]
5. Flecainide acetate in the treatment of supraventricular tachycardias: value of programmed electrical stimulation for long-term prognosis.
van Wijk LM; Crijns HJ; van Gilst WH; Wesseling H; Lie KI
Am Heart J; 1989 Feb; 117(2):365-9. PubMed ID: 2492738
[TBL] [Abstract][Full Text] [Related]
6. [The pharmacological treatment of supraventricular atrioventricular nodal reentry or accessory pathway reentry tachycardias: the usefulness of transesophageal electrophysiological study in the selection of therapy].
Sarubbi B; Ducceschi V; Esposito R; Briglia N; Manzo G; Mayer MS; Santangelo L; Iacono A
Cardiologia; 1996 Jun; 41(6):543-9. PubMed ID: 8766417
[TBL] [Abstract][Full Text] [Related]
7. Double-blind study of intravenous propafenone for paroxysmal supraventricular reentrant tachycardia.
Hammill SC; McLaran CJ; Wood DL; Osborn MJ; Gersh BJ; Holmes DR
J Am Coll Cardiol; 1987 Jun; 9(6):1364-8. PubMed ID: 3584724
[TBL] [Abstract][Full Text] [Related]
8. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
Musto B; Cavallaro C; Musto A; D'Onofrio A; Belli A; De Vincentis L
Am Heart J; 1992 Jul; 124(1):110-5. PubMed ID: 1615792
[TBL] [Abstract][Full Text] [Related]
9. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A
Circulation; 1988 Oct; 78(4):863-9. PubMed ID: 3168194
[TBL] [Abstract][Full Text] [Related]
10. A comparison of intravenous propafenone and flecainide in the treatment of tachycardias associated with the Wolff-Parkinson-White syndrome.
O'Nunain S; Garratt CJ; Linker NJ; Gill J; Ward DE; Camm AJ
Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):2028-34. PubMed ID: 1721219
[TBL] [Abstract][Full Text] [Related]
11. Intravenous flecainide acetate for supraventricular tachycardias.
Hellestrand KJ
Am J Cardiol; 1988 Aug; 62(6):16D-22D. PubMed ID: 3136630
[TBL] [Abstract][Full Text] [Related]
12. Current treatment options for paroxysmal supraventricular tachycardia.
Mannino MM; Mehta D; Gomes JA
Am Heart J; 1994 Feb; 127(2):475-80. PubMed ID: 8296727
[No Abstract] [Full Text] [Related]
13. Long-term efficacy and safety of flecainide for supraventricular tachycardia.
Neuss H; Schlepper M
Am J Cardiol; 1988 Aug; 62(6):56D-61D. PubMed ID: 3136637
[TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
Hoff PI; Tronstad A; Oie B; Ohm OJ
Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
[TBL] [Abstract][Full Text] [Related]
15. [The study of acute clinical electrophysiological effects of propafenone on paroxysmal supraventricular tachycardia using transesophageal atrial pacing technique].
Li Q; Wang Z; Peng D
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(2):123-6. PubMed ID: 9868052
[TBL] [Abstract][Full Text] [Related]
16. Short- and long-term efficacy and safety of flecainide acetate for supraventricular arrhythmias.
Hohnloser SH; Zabel M
Am J Cardiol; 1992 Aug; 70(5):3A-9A; discussion 9A-10A. PubMed ID: 1387287
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
Musto B; D'Onofrio A; Cavallaro C; Musto A; Greco R
Am J Cardiol; 1988 Aug; 62(4):229-33. PubMed ID: 3135739
[TBL] [Abstract][Full Text] [Related]
18. Paroxysmal supraventricular tachycardia: experience with propafenone.
Santinelli V; De Paola M; Turco P; Smimmo D; Chiariello M
Angiology; 1989 Jun; 40(6):563-8. PubMed ID: 2719341
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of transesophageal electrophysiological study during the ergometric test in the evaluation of supraventricular paroxysmal tachycardia occurring during exertion].
Delise P; D'Este D; Bonso A; Allibardi P; Raviele A; Di Pede F; Piccolo E
G Ital Cardiol; 1989 Dec; 19(12):1094-104. PubMed ID: 2576799
[TBL] [Abstract][Full Text] [Related]
20. [Tachycardias: considerations in childhood in the 90s].
Gutiérrez-Larraya F; Jabón A
An Esp Pediatr; 1993 Dec; 39(6):475-88. PubMed ID: 8166400
[No Abstract] [Full Text] [Related]
[Next] [New Search]
